GB9725346D0 - Pharmaceutical composition for the treatment of inflammatory bowel disease - Google Patents

Pharmaceutical composition for the treatment of inflammatory bowel disease

Info

Publication number
GB9725346D0
GB9725346D0 GBGB9725346.2A GB9725346A GB9725346D0 GB 9725346 D0 GB9725346 D0 GB 9725346D0 GB 9725346 A GB9725346 A GB 9725346A GB 9725346 D0 GB9725346 D0 GB 9725346D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9725346.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech Pharma Europe Ltd
Original Assignee
Medeva Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeva Europe Ltd filed Critical Medeva Europe Ltd
Priority to GBGB9725346.2A priority Critical patent/GB9725346D0/en
Publication of GB9725346D0 publication Critical patent/GB9725346D0/en
Priority to US09/508,661 priority patent/US7341741B1/en
Priority to ES98944115T priority patent/ES2224428T3/en
Priority to AT98944115T priority patent/ATE269710T1/en
Priority to DK98944115T priority patent/DK1017404T3/en
Priority to CA002304948A priority patent/CA2304948C/en
Priority to AU91780/98A priority patent/AU758501B2/en
Priority to EP98944115A priority patent/EP1017404B1/en
Priority to PT98944115T priority patent/PT1017404E/en
Priority to PCT/GB1998/002899 priority patent/WO1999016454A1/en
Priority to JP2000513588A priority patent/JP4180791B2/en
Priority to DE69824748T priority patent/DE69824748T2/en
Priority to JP2008018436A priority patent/JP2008143914A/en
Ceased legal-status Critical Current

Links

GBGB9725346.2A 1997-09-26 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease Ceased GB9725346D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease
DE69824748T DE69824748T2 (en) 1997-09-26 1998-09-25 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFUSED STOMACH DISEASES
AU91780/98A AU758501B2 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
ES98944115T ES2224428T3 (en) 1997-09-26 1998-09-25 PHARMNACEUTICAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLMATORY DISEASE.
AT98944115T ATE269710T1 (en) 1997-09-26 1998-09-25 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
DK98944115T DK1017404T3 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
CA002304948A CA2304948C (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
US09/508,661 US7341741B1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
EP98944115A EP1017404B1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
PT98944115T PT1017404E (en) 1997-09-26 1998-09-25 PHARMACEUTICAL FORMULA FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE
PCT/GB1998/002899 WO1999016454A1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
JP2000513588A JP4180791B2 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for treating inflammatory bowel disease
JP2008018436A JP2008143914A (en) 1997-09-26 2008-01-30 Pharmaceutical composition for treating inflammatory bowel disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
GB9725346D0 true GB9725346D0 (en) 1998-01-28

Family

ID=10822890

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9725346.2A Ceased GB9725346D0 (en) 1997-09-26 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease

Country Status (1)

Country Link
GB (1) GB9725346D0 (en)

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
ZA987552B (en) Pharmaceutical composition for combination of piperidino-alkanol-decongestant
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
EP1240136A4 (en) Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease
IL117417A (en) Pharmaceutical composition comprising rapamycin for treating cardiac inflammatory disease and its preparation
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
ZA988920B (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
KR970000230A (en) Cappa-Opide agonist for the treatment of inflammatory bowel disease
GB9706842D0 (en) Pharmaceutical compositions for the treatment of rhinitis
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
HUP0101514A3 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
GB9725346D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HUP9903685A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression
GB9817348D0 (en) Pharmaceutical use of esters
ZA986324B (en) Composition for the treatment of immunodeficiency disease
GB2354946B (en) Means for the treatment of prion disease
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
HUP0001499A3 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)